16:39 EST Lyell Immunopharma (LYEL) files to sell 1.9M shares of common stock for holders
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LYEL:
- Lyell Immunopharma Modernizes Bylaws for Shareholder Engagement
- Lyell Immunopharma price target raised to $20 from $10 at H.C. Wainwright
- Lyell Immunopharma Reports Q3 2025 Financial Results
- Lyell Immunopharma reports Q3 revenue $15k vs $34k last year
- Lyell Immunopharma acquires exclusive global rights to LYL273